مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

101
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

274
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings

Pages

  167-176

Abstract

 Background: The International Agency for Research on Cancer (IARC) recently classified Opium use as a Group 1 carcinogen. However, much remains to be studied on the relation between Opium and cancer. We designed the Iranian Opium and Cancer (IROPICAN) study to further investigate the association of Opium use and cancers of the head and neck, bladder, lung, and colon and rectum. In this paper, we describe the rationale, design, and some initial results of the IROPICAN Study. Methods: The IROPICAN is a multi-center case-control study conducted in 10 provinces of Iran. The cases were all histologically confirmed and the controls were selected from hospital visitors who were free of cancer, were not family members or friends of the cancer patients, and were visiting the hospital for reasons other than their own ailment. The questionnaires included detailed questions on Opium use (including age at initiation, duration, frequency, typical amount, and route), and potential confounders, such as tobacco use (e. g., cigarettes, nass and water-pipe), and dietary factors. Biological samples, including blood and saliva, were also collected. Results: The validation and pilot phases showed reasonably good validity, with sensitivities of 70% and 69% for the cases and controls, respectively, in reporting Opium use. The results also showed excellent reliability, with intra-class correlation coefficients of 0. 96 for ever Opium use and 0. 88 (95% CI: 0. 80, 0. 92) for regular Opium use. In the main phase, we recruited 3299 cancer cases (99% response rate) and 3477 hospital visitor controls (89% response rate). The proportion of ever-use of Opium was 40% among cases and 18% among controls. Conclusion: The IROPICAN study will serve as a major resource in studies addressing the effect of Opium on risk of cancers of the head and neck, bladder, lung, and colon and rectum.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    HADJI, MARYAM, RASHIDIAN, HAMIDEH, MARZBAN, MARYAM, GHOLIPOUR, MAHIN, NAGHIBZADEH TAHAMI, AHMAD, MOHEBBI, ELHAM, EBRAHIMI, ELMIRA, HOSSEINI, BAYAN, HAGHDOOST, ALI AKBAR, REZAIANZADEH, ABBAS, RAHIMI MOVAGHAR, AFARIN, MORADI, ABDOLVAHAB, Seyyedsalehi, Monireh Sadat, SHIRKOOHI, REZA, POUSTCHI, HOSSEIN, NAJAFI, FARID, SAFARI FARAMANI, ROYA, ALIZADEH NAVAEI, REZA, ANSARI MOGHADAM, ALIREZA, BAKHSHI, MAHDIEH, NEJATIZADEH, AZIM, Mahmudi, Masumeh, SHAHID SALES, SOUDABEH, Ahmadi Simab, Saideh, NABAVIAN, OMID, BOFFETTA, PAOLO, Pukkala, Eero, WEIDERPASS, ELISABETE, KAMANGAR, FARIN, & ZENDEHDEL, KAZEM. (2021). The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings. ARCHIVES OF IRANIAN MEDICINE, 24(3), 167-176. SID. https://sid.ir/paper/678350/en

    Vancouver: Copy

    HADJI MARYAM, RASHIDIAN HAMIDEH, MARZBAN MARYAM, GHOLIPOUR MAHIN, NAGHIBZADEH TAHAMI AHMAD, MOHEBBI ELHAM, EBRAHIMI ELMIRA, HOSSEINI BAYAN, HAGHDOOST ALI AKBAR, REZAIANZADEH ABBAS, RAHIMI MOVAGHAR AFARIN, MORADI ABDOLVAHAB, Seyyedsalehi Monireh Sadat, SHIRKOOHI REZA, POUSTCHI HOSSEIN, NAJAFI FARID, SAFARI FARAMANI ROYA, ALIZADEH NAVAEI REZA, ANSARI MOGHADAM ALIREZA, BAKHSHI MAHDIEH, NEJATIZADEH AZIM, Mahmudi Masumeh, SHAHID SALES SOUDABEH, Ahmadi Simab Saideh, NABAVIAN OMID, BOFFETTA PAOLO, Pukkala Eero, WEIDERPASS ELISABETE, KAMANGAR FARIN, ZENDEHDEL KAZEM. The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings. ARCHIVES OF IRANIAN MEDICINE[Internet]. 2021;24(3):167-176. Available from: https://sid.ir/paper/678350/en

    IEEE: Copy

    MARYAM HADJI, HAMIDEH RASHIDIAN, MARYAM MARZBAN, MAHIN GHOLIPOUR, AHMAD NAGHIBZADEH TAHAMI, ELHAM MOHEBBI, ELMIRA EBRAHIMI, BAYAN HOSSEINI, ALI AKBAR HAGHDOOST, ABBAS REZAIANZADEH, AFARIN RAHIMI MOVAGHAR, ABDOLVAHAB MORADI, Monireh Sadat Seyyedsalehi, REZA SHIRKOOHI, HOSSEIN POUSTCHI, FARID NAJAFI, ROYA SAFARI FARAMANI, REZA ALIZADEH NAVAEI, ALIREZA ANSARI MOGHADAM, MAHDIEH BAKHSHI, AZIM NEJATIZADEH, Masumeh Mahmudi, SOUDABEH SHAHID SALES, Saideh Ahmadi Simab, OMID NABAVIAN, PAOLO BOFFETTA, Eero Pukkala, ELISABETE WEIDERPASS, FARIN KAMANGAR, and KAZEM ZENDEHDEL, “The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings,” ARCHIVES OF IRANIAN MEDICINE, vol. 24, no. 3, pp. 167–176, 2021, [Online]. Available: https://sid.ir/paper/678350/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button